Search for Clinical Trial Results
Hemophilia B - 30 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B Condition: Hemophilia B Date: 2012-08-27 Interventions: Biological: AskBio009 Single dose IV injection Other |
Completed |
Study Name: Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B Condition: Hemophilia B Date: 2007-06-07 Interventions: Drug: BeneFIX (coagulation factor IX (recombinant)) BeneFIX will be administered according to physician' |
Recruiting |
Study Name: Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B Condition: Hemophilia B Date: 2009-09-16 Interventions:
|
Completed |
Study Name: Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX) Condition: Hemophilia B Date: 2005-08-30 Interventions: Drug: human coagulation Factor IX Other Name: Nonafact |
Terminated |
Study Name: Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B Condition: Hemophilia B Date: 2004-01-26 Interventions: Genetic: Adeno-Associated Viral with Human Factor IX |
Completed |
Study Name: Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients Condition: Hemophilia B Date: 2005-10-19 Interventions:
|
Terminated |
Study Name: Hemophilia B Gene Therapy With AAV8 Vector Condition: Hemophilia B Date: 2012-06-12 Interventions: Biological: AAV8-hFIX19 One-time IV vector administration. |
Recruiting |
Study Name: A Gene Therapy Study for Hemophilia B Condition: Hemophilia B Date: 2015-06-18 Interventions: Genetic: SPK-9001 A novel, bioengineered adeno-associated viral vector carrying human factor IX variant |
Active, not recruiting |
Study Name: LTFU for Gene Transfer Subjects With Hemophilia B Condition: Hemophilia B Date: 2007-08-10 |
Completed |
Study Name: BeneFIX Drug Use Results Survey [All-Case Surveillance] Condition: Hemophilia B Date: 2010-06-28 Interventions: Drug: Nonacog Alfa (Genetical Recombination) Patients with |